BNTX logo

BioNTech SE (BNTX) Revenue

Annual revenue:

$2.98B-$1.15B(-27.92%)
December 31, 2024

Summary

  • As of today (August 17, 2025), BNTX annual revenue is $2.98 billion, with the most recent change of -$1.15 billion (-27.92%) on December 31, 2024.
  • During the last 3 years, BNTX annual revenue has fallen by -$19.45 billion (-86.73%).
  • BNTX annual revenue is now -86.73% below its all-time high of $22.43 billion, reached on December 31, 2021.

Performance

BNTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly revenue:

$295.83M+$103.44M(+53.77%)
June 30, 2025

Summary

  • As of today (August 17, 2025), BNTX quarterly revenue is $295.83 million, with the most recent change of +$103.44 million (+53.77%) on June 30, 2025.
  • Over the past year, BNTX quarterly revenue has increased by +$157.28 million (+113.52%).
  • BNTX quarterly revenue is now -95.88% below its all-time high of $7.18 billion, reached on September 30, 2021.

Performance

BNTX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM revenue:

$3.13B+$157.28M(+5.30%)
June 30, 2025

Summary

  • As of today (August 17, 2025), BNTX TTM revenue is $3.13 billion, with the most recent change of +$157.28 million (+5.30%) on June 30, 2025.
  • Over the past year, BNTX TTM revenue has increased by +$218.41 million (+7.51%).
  • BNTX TTM revenue is now -88.45% below its all-time high of $27.05 billion, reached on March 31, 2022.

Performance

BNTX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

BNTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.9%+113.5%+7.5%
3 y3 years-86.7%-91.3%-87.0%
5 y5 years+2348.5%+543.2%+2142.8%

BNTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-86.7%at low-93.2%+113.5%-87.0%+7.5%
5 y5-year-86.7%+2348.5%-95.9%+543.2%-88.5%+2142.8%
alltimeall time-86.7%+4183.1%-95.9%+1147.3%-88.5%>+9999.0%

BNTX Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$295.83M(+53.8%)
$3.13B(+5.3%)
Mar 2025
-
$192.39M(-84.8%)
$2.97B(-0.4%)
Dec 2024
$2.98B(-27.9%)
$1.27B(-7.2%)
$2.98B(-9.7%)
Sep 2024
-
$1.37B(+887.0%)
$3.30B(+13.5%)
Jun 2024
-
$138.55M(-32.0%)
$2.91B(-1.5%)
Mar 2024
-
$203.61M(-87.2%)
$2.95B(-28.3%)
Dec 2023
$4.13B(-77.3%)
$1.59B(+63.3%)
$4.12B(-40.3%)
Sep 2023
-
$973.94M(+433.6%)
$6.89B(-26.7%)
Jun 2023
-
$182.51M(-86.7%)
$9.40B(-25.5%)
Mar 2023
-
$1.37B(-68.6%)
$12.62B(-31.4%)
Dec 2022
$18.19B(-18.9%)
$4.36B(+25.2%)
$18.40B(-9.6%)
Sep 2022
-
$3.48B(+2.4%)
$20.36B(-15.3%)
Jun 2022
-
$3.40B(-52.4%)
$24.05B(-11.1%)
Mar 2022
-
$7.15B(+13.1%)
$27.05B(+20.9%)
DateAnnualQuarterlyTTM
Dec 2021
$22.43B(+3979.4%)
$6.32B(-11.9%)
$22.37B(+35.9%)
Sep 2021
-
$7.18B(+12.1%)
$16.45B(+75.8%)
Jun 2021
-
$6.40B(+159.4%)
$9.36B(+211.5%)
Mar 2021
-
$2.47B(+499.1%)
$3.00B(+429.7%)
Dec 2020
$549.84M(+352.4%)
$411.83M(+422.3%)
$567.14M(+204.4%)
Sep 2020
-
$78.84M(+71.4%)
$186.32M(+33.7%)
Jun 2020
-
$45.99M(+50.9%)
$139.34M(+13.9%)
Mar 2020
-
$30.48M(-1.7%)
$122.32M(+0.6%)
Dec 2019
$121.54M(-19.2%)
$31.00M(-2.7%)
$121.55M(-25.6%)
Sep 2019
-
$31.87M(+10.0%)
$163.31M(+5.3%)
Jun 2019
-
$28.97M(-2.5%)
$155.16M(+23.0%)
Mar 2019
-
$29.71M(-59.2%)
$126.19M(+30.8%)
Dec 2018
$150.51M(+116.6%)
$72.77M(+206.8%)
$96.49M(+306.8%)
Sep 2018
-
$23.72M
$23.72M
Dec 2017
$69.48M
-
-

FAQ

  • What is BioNTech SE annual revenue?
  • What is the all time high annual revenue for BioNTech SE?
  • What is BioNTech SE annual revenue year-on-year change?
  • What is BioNTech SE quarterly revenue?
  • What is the all time high quarterly revenue for BioNTech SE?
  • What is BioNTech SE quarterly revenue year-on-year change?
  • What is BioNTech SE TTM revenue?
  • What is the all time high TTM revenue for BioNTech SE?
  • What is BioNTech SE TTM revenue year-on-year change?

What is BioNTech SE annual revenue?

The current annual revenue of BNTX is $2.98B

What is the all time high annual revenue for BioNTech SE?

BioNTech SE all-time high annual revenue is $22.43B

What is BioNTech SE annual revenue year-on-year change?

Over the past year, BNTX annual revenue has changed by -$1.15B (-27.92%)

What is BioNTech SE quarterly revenue?

The current quarterly revenue of BNTX is $295.83M

What is the all time high quarterly revenue for BioNTech SE?

BioNTech SE all-time high quarterly revenue is $7.18B

What is BioNTech SE quarterly revenue year-on-year change?

Over the past year, BNTX quarterly revenue has changed by +$157.28M (+113.52%)

What is BioNTech SE TTM revenue?

The current TTM revenue of BNTX is $3.13B

What is the all time high TTM revenue for BioNTech SE?

BioNTech SE all-time high TTM revenue is $27.05B

What is BioNTech SE TTM revenue year-on-year change?

Over the past year, BNTX TTM revenue has changed by +$218.41M (+7.51%)
On this page